taxonomy (1)
protein (1)
source (2)
structure (0)
composition (25)
disease (2)
reference (2)
site (6)
peptide (6)
- Homo sapiens (Human)
Taxonomy
Reported structure
- Hex:3 HexNAc:6 (avg mass : 1723.6125 )
- Hex:4 HexNAc:3 NeuAc:1 (avg mass : 1567.4278 )
- Hex:4 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2062.9088 )
- Hex:5 HexNAc:3 dHex:1 NeuAc:1 (avg mass : 1875.7132 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:2 (avg mass : 2516.3091 )
- Hex:6 HexNAc:3 dHex:1 (avg mass : 1746.5977 )
- Hex:6 HexNAc:4 NeuAc:1 (avg mass : 2094.9076 )
- Hex:6 HexNAc:5 NeuAc:1 (avg mass : 2298.1026 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2444.2456 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2735.5035 )
- Hex:6 HexNAc:5 dHex:2 NeuAc:2 (avg mass : 2881.6465 )
- Hex:6 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3229.9564 )
- Hex:6 HexNAc:6 dHex:2 NeuAc:2
- Hex:6 HexNAc:6 dHex:2 NeuAc:3
- Hex:6 HexNAc:6 dHex:3 NeuAc:3 (avg mass : 3522.2424 )
- Hex:7 HexNAc:6 NeuAc:2 (avg mass : 2954.6979 )
- Hex:7 HexNAc:6 NeuAc:3 (avg mass : 3245.9558 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 3100.8409 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3392.0988 )
- Hex:7 HexNAc:6 dHex:2 NeuAc:3
- Hex:12 HexNAc:2 (avg mass : 2370.1141 )
Composition
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
Reference
- VHINTTSDSILLK (13aa)
- QVIQNVTHK (9aa)
- APLGGVILVHLIIPGLNETTVK (22aa)
- NETLALPAESK (11aa)
- NVSVDSTHPTK (11aa)
- ENGSFSGK (8aa)
Mass spectrometry observed peptide
-
- Hex:4 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1567.4278)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Target of Nesh-SH3 / Homo sapiens
- ENGSFSGK (8aa)
-
- Hex:3 HexNAc:6 / N-Linked (avg mass : 1723.6125)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Target of Nesh-SH3 / Homo sapiens
- ENGSFSGK (8aa)
-
- Hex:6 HexNAc:3 dHex:1 / N-Linked (avg mass : 1746.5977)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Target of Nesh-SH3 / Homo sapiens
- ENGSFSGK (8aa)
-
- Hex:5 HexNAc:4 dHex:1 / N-Linked (avg mass : 1787.6503)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Target of Nesh-SH3 / Homo sapiens
- QVIQNVTHK (9aa)
-
- Hex:5 HexNAc:3 dHex:1 NeuAc:1 / N-Linked (avg mass : 1875.7132)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Target of Nesh-SH3 / Homo sapiens
- NETLALPAESK (11aa)
-
- Hex:5 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1932.7652)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Target of Nesh-SH3 / Homo sapiens
- VHINTTSDSILLK (13aa)
-
- Hex:4 HexNAc:4 dHex:2 NeuAc:1 / N-Linked (avg mass : 2062.9088)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Target of Nesh-SH3 / Homo sapiens
- QVIQNVTHK (9aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2078.9082)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Target of Nesh-SH3 / Homo sapiens
- VHINTTSDSILLK (13aa)
- QVIQNVTHK (9aa)
- APLGGVILVHLIIPGLNETTVK (22aa)
-
- Hex:6 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 2094.9076)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Target of Nesh-SH3 / Homo sapiens
- ENGSFSGK (8aa)
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 2224.0231)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Target of Nesh-SH3 / Homo sapiens
- VHINTTSDSILLK (13aa)
- NETLALPAESK (11aa)
-
- Hex:6 HexNAc:5 NeuAc:1 / N-Linked (avg mass : 2298.1026)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Target of Nesh-SH3 / Homo sapiens
- NVSVDSTHPTK (11aa)
-
- Hex:12 HexNAc:2 / N-Linked (avg mass : 2370.1141)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Target of Nesh-SH3 / Homo sapiens
- VHINTTSDSILLK (13aa)
- QVIQNVTHK (9aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 / N-Linked (avg mass : 2444.2456)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Target of Nesh-SH3 / Homo sapiens
- NETLALPAESK (11aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:2 / N-Linked (avg mass : 2516.3091)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Target of Nesh-SH3 / Homo sapiens
- NVSVDSTHPTK (11aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 / N-Linked (avg mass : 2735.5035)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Target of Nesh-SH3 / Homo sapiens
- NETLALPAESK (11aa)
- NVSVDSTHPTK (11aa)
-
- Hex:6 HexNAc:5 dHex:2 NeuAc:2 / N-Linked (avg mass : 2881.6465)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Target of Nesh-SH3 / Homo sapiens
- QVIQNVTHK (9aa)
-
- Hex:7 HexNAc:6 NeuAc:2 / N-Linked (avg mass : 2954.6979)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Target of Nesh-SH3 / Homo sapiens
- QVIQNVTHK (9aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 / N-Linked (avg mass : 3100.8409)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Target of Nesh-SH3 / Homo sapiens
- NETLALPAESK (11aa)
-
- Hex:6 HexNAc:6 dHex:1 NeuAc:3 / N-Linked (avg mass : 3229.9564)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Target of Nesh-SH3 / Homo sapiens
- VHINTTSDSILLK (13aa)
-
- Hex:6 HexNAc:6 dHex:2 NeuAc:2 / N-Linked
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Target of Nesh-SH3 / Homo sapiens
- ENGSFSGK (8aa)
-
- Hex:6 HexNAc:6 dHex:2 NeuAc:3 / N-Linked
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Target of Nesh-SH3 / Homo sapiens
- VHINTTSDSILLK (13aa)
- NVSVDSTHPTK (11aa)
-
- Hex:7 HexNAc:6 NeuAc:3 / N-Linked (avg mass : 3245.9558)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Target of Nesh-SH3 / Homo sapiens
- QVIQNVTHK (9aa)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 / N-Linked (avg mass : 3392.0988)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Target of Nesh-SH3 / Homo sapiens
- NETLALPAESK (11aa)
-
- Hex:6 HexNAc:6 dHex:3 NeuAc:3 / N-Linked (avg mass : 3522.2424)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Target of Nesh-SH3 / Homo sapiens
- NVSVDSTHPTK (11aa)
-
- Hex:7 HexNAc:6 dHex:2 NeuAc:3 / N-Linked
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Target of Nesh-SH3 / Homo sapiens
- NETLALPAESK (11aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
